286 related articles for article (PubMed ID: 27580024)
1. Therapeutic design of peptide modulators of protein-protein interactions in membranes.
Stone TA; Deber CM
Biochim Biophys Acta Biomembr; 2017 Apr; 1859(4):577-585. PubMed ID: 27580024
[TBL] [Abstract][Full Text] [Related]
2. Helix-helix interactions in membrane domains of bitopic proteins: Specificity and role of lipid environment.
Bocharov EV; Mineev KS; Pavlov KV; Akimov SA; Kuznetsov AS; Efremov RG; Arseniev AS
Biochim Biophys Acta Biomembr; 2017 Apr; 1859(4):561-576. PubMed ID: 27884807
[TBL] [Abstract][Full Text] [Related]
3. Peptidomimetics - An infinite reservoir of metal binding motifs in metabolically stable and biologically active molecules.
Wątły J; Miller A; Kozłowski H; Rowińska-Żyrek M
J Inorg Biochem; 2021 Apr; 217():111386. PubMed ID: 33610030
[TBL] [Abstract][Full Text] [Related]
4. Membrane adsorption and binding, cellular uptake and cytotoxicity of cell-penetrating peptidomimetics with α-peptide/β-peptoid backbone: effects of hydrogen bonding and α-chirality in the β-peptoid residues.
Jing X; Yang M; Kasimova MR; Malmsten M; Franzyk H; Jorgensen L; Foged C; Nielsen HM
Biochim Biophys Acta; 2012 Nov; 1818(11):2660-8. PubMed ID: 22609348
[TBL] [Abstract][Full Text] [Related]
5. Interactions between misfolded protein oligomers and membranes: A central topic in neurodegenerative diseases?
Andreasen M; Lorenzen N; Otzen D
Biochim Biophys Acta; 2015 Sep; 1848(9):1897-907. PubMed ID: 25666871
[TBL] [Abstract][Full Text] [Related]
6. A Mini-Review on the Effectiveness of Peptoids as Therapeutic Interventions against Neurodegenerative Diseases.
Paul SS; Biswas G
Curr Protein Pept Sci; 2021; 22(7):526-533. PubMed ID: 34137361
[TBL] [Abstract][Full Text] [Related]
7. Helix formation and stability in membranes.
McKay MJ; Afrose F; Koeppe RE; Greathouse DV
Biochim Biophys Acta Biomembr; 2018 Oct; 1860(10):2108-2117. PubMed ID: 29447916
[TBL] [Abstract][Full Text] [Related]
8. Cyclic Peptides for Protein-Protein Interaction Targets: Applications to Human Disease.
Rubin S; Qvit N
Crit Rev Eukaryot Gene Expr; 2016; 26(3):199-221. PubMed ID: 27650985
[TBL] [Abstract][Full Text] [Related]
9. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
[TBL] [Abstract][Full Text] [Related]
10. Constraining cyclic peptides to mimic protein structure motifs.
Hill TA; Shepherd NE; Diness F; Fairlie DP
Angew Chem Int Ed Engl; 2014 Nov; 53(48):13020-41. PubMed ID: 25287434
[TBL] [Abstract][Full Text] [Related]
11. Peptides and proteins as a continuing exciting source of inspiration for peptidomimetics.
Liskamp RM; Rijkers DT; Kruijtzer JA; Kemmink J
Chembiochem; 2011 Jul; 12(11):1626-53. PubMed ID: 21751324
[TBL] [Abstract][Full Text] [Related]
12. Cofactor-free detection of phosphatidylserine with cyclic peptides mimicking lactadherin.
Zheng H; Wang F; Wang Q; Gao J
J Am Chem Soc; 2011 Oct; 133(39):15280-3. PubMed ID: 21899316
[TBL] [Abstract][Full Text] [Related]
13. Peptides and peptidomimetics as inhibitors of protein-protein interactions involving β-sheet secondary structures.
Laxio Arenas J; Kaffy J; Ongeri S
Curr Opin Chem Biol; 2019 Oct; 52():157-167. PubMed ID: 31590141
[TBL] [Abstract][Full Text] [Related]
14. New insights into the molecular mechanisms of biomembrane structural changes and interactions by optical biosensor technology.
Lee TH; Hirst DJ; Aguilar MI
Biochim Biophys Acta; 2015 Sep; 1848(9):1868-85. PubMed ID: 26009270
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of trivalent cyclic hexapeptides to induce lipid clustering in PG/PE membranes correlates with their antimicrobial activity.
Finger S; Kerth A; Dathe M; Blume A
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2998-3006. PubMed ID: 26367060
[TBL] [Abstract][Full Text] [Related]
16. Directed Evolution of a Cyclized Peptoid-Peptide Chimera against a Cell-Free Expressed Protein and Proteomic Profiling of the Interacting Proteins to Create a Protein-Protein Interaction Inhibitor.
Kawakami T; Ogawa K; Hatta T; Goshima N; Natsume T
ACS Chem Biol; 2016 Jun; 11(6):1569-77. PubMed ID: 27010125
[TBL] [Abstract][Full Text] [Related]
17. Tailoring peptidomimetics for targeting protein-protein interactions.
Akram ON; DeGraff DJ; Sheehan JH; Tilley WD; Matusik RJ; Ahn JM; Raj GV
Mol Cancer Res; 2014 Jul; 12(7):967-78. PubMed ID: 24642350
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Synthesis and Identification of Cyclic Peptides for Bioapplications.
Ong YS; Gao L; Kalesh KA; Yu Z; Wang J; Liu C; Li Y; Sun H; Lee SS
Curr Top Med Chem; 2017; 17(20):2302-2318. PubMed ID: 28240181
[TBL] [Abstract][Full Text] [Related]
19. The electrical interplay between proteins and lipids in membranes.
Richens JL; Lane JS; Bramble JP; O'Shea P
Biochim Biophys Acta; 2015 Sep; 1848(9):1828-36. PubMed ID: 25817548
[TBL] [Abstract][Full Text] [Related]
20. Disordered proteins: biological membranes as two-dimensional aggregation matrices.
Byström R; Aisenbrey C; Borowik T; Bokvist M; Lindström F; Sani MA; Olofsson A; Gröbner G
Cell Biochem Biophys; 2008; 52(3):175-89. PubMed ID: 18975139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
